All News

Gene Editing

Integra Therapeutics Presented ex vivoand in vivoData for its FiCAT Gene Writing Platform at Advanced Therapies Europe
12 September 2023
Integra Therapeutics Presented ex vivoand in vivoData for its FiCAT Gene Writing Platform at Advanced Therapies Europe
Integra Therapeutics presented positive data
Beam Therapeutics Announced First Patient Dosed in Phase I/II Trial in Relapsed, Refractory T-ALL/T-LL
6 September 2023
Beam Therapeutics Announced First Patient Dosed in Phase I/II Trial in Relapsed, Refractory T-ALL/T-LL
Beam Therapeutics Announced First Patient
Precision BioSciences Completes Strategic $227M Transaction with Imugene for CAR-T Therapy
17 August 2023
Precision BioSciences Completes Strategic $227M Transaction with Imugene for CAR-T Therapy
Precision BioSciences Completes Strategic Transaction
Scribe and Sanofi Expand Collaboration Further to Advance Genetic Treatments
18 July 2023
Scribe and Sanofi Expand Collaboration Further to Advance Genetic Treatments
Scribe and Sanofi Expand Collaboration
POPULAR NEWS ITEMS
Image
21 September 2023

Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment

Image
20 September 2023

Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux

Image
20 September 2023

The Cell & Gene Therapy Manufacturing Capacity Map

MaxCyte and Vittoria Biotherapeutics Partner to Propel Next-Generation Cellular Therapies through Strategic Platform License
11 July 2023
MaxCyte and Vittoria Biotherapeutics Partner to Propel Next-Generation Cellular Therapies through Strategic Platform License
MaxCyte and Vittoria have recently
Cell and Gene Therapy Summit – Conversations Dedicated to Manufacturing Challenges, Investment Opportunities and Regulatory Harmonization
15 June 2023
Cell and Gene Therapy Summit – Conversations Dedicated to Manufacturing Challenges, Investment Opportunities and Regulatory Harmonization
The Phacilitate Editorial team was
Off-the-Shelf Lentiviral Vector Packaging Plasmids Launched by Charles River
13 June 2023
Off-the-Shelf Lentiviral Vector Packaging Plasmids Launched by Charles River
During the London leg of
FDA Grants Approval to First Ever Topical Gene Therapy
23 May 2023
FDA Grants Approval to First Ever Topical Gene Therapy
The FDA has granted approval
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

Taysha Gene Therapies Halts its TSHA-120 Program for Giant Axonal Neuropathy Treatment

Image

Oxford Biomedica Explores Acquisition of ABL Europe in Collaboration with Institut Mérieux

Image

The Cell & Gene Therapy Manufacturing Capacity Map